Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP‐induced platelet activation

Background: Platelet response to activating agents is used to monitor the efficacy of anti‐aggregation therapies. The aim of our study has been to demonstrate the existence of relationships between early events of ADP‐induced platelet activation, measured by flow cytometry and platelet‐rich plasma a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cytometry. Part B, Clinical cytometry Clinical cytometry, 2008-01, Vol.74B (1), p.30-39
Hauptverfasser: Sbrana, Silverio, Della Pina, Francesca, Rizza, Antonio, Buffa, Manuela, De Filippis, Rossella, Gianetti, Jacopo, Clerico, Aldo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Platelet response to activating agents is used to monitor the efficacy of anti‐aggregation therapies. The aim of our study has been to demonstrate the existence of relationships between early events of ADP‐induced platelet activation, measured by flow cytometry and platelet‐rich plasma aggregation, quantified by optical aggregometry. Methods: We evaluated peripheral blood of 12 donors. The following parameters were quantified by cytometry after stimulation with adenosine diphosphate (ADP) (0.5, 1, 2, 5, 10, 20 μM): CD62P (P‐selectin) and PAC‐1 expression, and cytosolic Ca2+ mobilization. Aggregation was measured by optical aggregometry. We also studied 13 patients, undergoing coronary stenting, treated with aspirin (before procedure) or with aspirin plus clopidogrel (after procedure). We evaluated CD62P and PAC‐1 expression, aggregation, and vasodilator‐stimulated phopshoprotein phosphorylation (platelet reactivity index, PRI). Results: Flow procedures were more sensitive than aggregometry, with a lowest interindividual variability. Linear relationships existed in donors between CD62P expression and Ca2+ mobilization (P < 0.0001), and between aggregation and Ca2+ mobilization (P < 0.0001). Linear relationships existed between aggregation and CD62P expression, as percentage (P < 0.0001), or relative fluorescence intensity (RFI) (P < 0.0001). Exponential equations related aggregation and PAC‐1 expression, as percentage (P < 0.0001), or RFI (P < 0.0001). Linear relationships between aggregation and CD62P expression (as percentage) existed in the patients before (P = 0.0022) and after procedure (P = 0.0020). Exponential relationships between aggregation and PAC‐1 expression (as percentage) existed before (P = 0.0012) and after procedure (P = 0.0024). Linear correlations related aggregation response predicted on CD62P expression, and measured aggregation inhibition after clopidogrel (P = 0.0013) as well as predicted aggregation and PRI inhibition (P = 0.0031). Conclusions: Tight relationships between aggregation and cytometric quantification of platelet markers in whole blood, in particular CD62P, allow to predict aggregation response to ADP from flow data in patients treated with aspirin alone or with aspirin plus clopidogrel. © 2007 Clinical Cytometry Society
ISSN:1552-4949
1552-4957
DOI:10.1002/cyto.b.20360